COVID-19 Clinical Trials Registered Worldwide for Drug Intervention: An Overview and Characteristic Analysis
Author:
Publisher
Informa UK Limited
Subject
Drug Discovery,Pharmaceutical Science,Pharmacology
Reference52 articles.
1. Review of the Clinical Characteristics of Coronavirus Disease 2019 (COVID-19)
2. Treatment options for COVID-19: The reality and challenges
3. Implications of the lack of a unified research project framework: an investigation into the registration of clinical trials of COVID-19
4. Exploring the characteristics, global distribution and reasons for retraction of published articles involving human research participants: A literature survey
5. Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Worldwide Trends in Registering Real-World Studies at ClinicalTrials.gov: A Cross-Sectional Analysis;International Journal of General Medicine;2023-03
2. Infliximab as a potential treatment for COVID-19;Expert Review of Anti-infective Therapy;2022-11-27
3. Drugs and convalescent plasma therapy for COVID-19: a survey of the interventional clinical studies in Italy after 1 year of pandemic;Trials;2022-06-22
4. Reprint of: Development of vaccines and vaccinal strategies against COVID-19: The information contributing to shared decision-making;La Presse Médicale Open;2022
5. Between two storms, vasoactive peptides or bradykinin underlie severity of COVID‐19?;Physiological Reports;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3